|
PALX Palomino Laboratories Inc 1938569 |
| Income Statement |
|
Net Income
|
2026-06-30
|
$-1,365,034.00 |
| Balance Sheet |
|
Current Assets
|
$19,593,359.00 |
|
Assets
|
$21,042,166.00 |
|
Current Liabilities
|
$368,885.00 |
|
Liabilities
|
$475,962.00 |
|
Equity
|
$20,566,204.00 |
|
Shares Out
|
23164539.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-2,237,975.00 |
|
Investing Cash Flow
|
$-1,259,652.00 |
| Market Analysis |
Market Cap
|
$370,632,624.00 |
|
Price
|
$14.25 |
|
BVPS
|
0.89 |
|
PB
|
17.98 |
|
EPS
|
-0.06 |
|
FCF
|
$-3,497,627.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-09-01 09:33:19 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-09-14 10:02:09 |
|
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view PALX documents filed with the SEC.
PALX Filings
Clear
